3.1 Fluid Balance & Electrolyte Homeostasis

Physiology of Neonatal Fluid & Electrolyte Balance

The neonatal fluid compartment differs significantly from that of older children and adults. At birth, total body water (TBW) represents a large percentage of body weight, inversely proportional to gestational age. In a term infant, TBW constitutes approximately 75% to 80% of body weight, whereas in an extremely low birth weight (ELBW) infant (<1000 grams), it can exceed 90%. The majority of this water resides in the extracellular fluid (ECF) compartment.

During the first 3 to 5 days of life, neonates experience a physiological contraction of the ECF compartment. This is characterized by a shift of water from the ECF to the intracellular fluid (ICF) and the excretion of excess water and sodium through the kidneys. This physiological diuresis results in a normal weight loss during the first week of life:

• Term infants: 5% to 10% weight loss, returning to birth weight by day of life (DOL) 7 to 10.
• Preterm infants: 10% to 15% weight loss, returning to birth weight by DOL 10 to 14.

Clinical management must allow for this physiological weight loss. Attempting to maintain birth weight by administering excessive fluids during this phase can lead to serious neonatal morbidities, including Patent Ductus Arteriosus (PDA), Necrotizing Enterocolitis (NEC), Bronchopulmonary Dysplasia (BPD), and intraventricular hemorrhage (IVH).

Fluid Requirements by Day of Life (DOL)

Fluid administration must be titrated daily based on weight changes, urine output, and serum electrolyte levels. General guidelines for daily fluid intake are as follows:

Insensible Water Loss (IWL)

Insensible water loss (IWL) is the invisible evaporation of water from the skin (transepidermal) and respiratory tract. It does not contain electrolytes. In ELBW infants, transepidermal water loss is the single largest contributor to fluid instability due to an immature, thin stratum corneum, lack of subcutaneous fat, and high body surface area-to-weight ratio.

Factors Influencing Insensible Water Loss

• Gestational Age: IWL is inversely related to gestational age. An infant born at 24 weeks gestation may have an IWL of 100 to 200 mL/kg/day on DOL 1 if kept in a dry environment, whereas a term infant's IWL is typically 15 to 30 mL/kg/day.
• Environmental Humidity: Raising incubator humidity to 85% to 95% in the first 1 to 2 weeks of life reduces transepidermal IWL by up to 80-90%.
• Radiant Warmers vs. Incubators: Radiant warmers increase IWL by approximately 50% to 100% compared to double-walled incubators.
• Phototherapy: Traditional overhead phototherapy increases IWL by 30% to 50% due to convective heat transfer (less pronounced with modern cool LED phototherapy).
• Skin Integrity: Defects such as gastroschisis, omphalocele, or neural tube defects (myelomeningocele) lead to massive evaporative water loss.
• Respiratory Status: Tachypnea increases respiratory IWL, whereas humidified mechanical ventilation decreases it.

---

Electrolyte Homeostasis

Electrolytes (sodium, potassium, calcium, and magnesium) must be closely monitored. Because of the physiological diuresis phase, sodium and potassium are typically withheld from IV fluids during the first 24 to 48 hours of life (DOL 1-2) unless serum levels warrant intervention.

Sodium (Na+)

• Normal Range: 135 to 145 mEq/L
• Hyponatremia (<135 mEq/L):
  • Dilutional Hyponatremia: Most common. Caused by excess fluid administration or Syndrome of Inappropriate Antidiuretic Hormone (SIADH). Characterized by low sodium, low serum osmolality (<270 mOsm/kg), and weight gain. Treatment is fluid restriction.
  • Depletional Hyponatremia: Caused by excessive renal loss (preterm kidneys have limited sodium reabsorption) or diuretic therapy (furosemide). Characterized by low sodium, weight loss, and high urine output. Treatment is sodium supplementation (normal maintenance is 2 to 4 mEq/kg/day, started on DOL 2-3).
  • Clinical Signs: Lethargy, hypotonia, apnea, and seizures (if sodium drops rapidly below 120 mEq/L).
• Hypernatremia (>145 mEq/L):
  • Dehydration Hypernatremia: Caused by inadequate fluid intake or high IWL. Characterized by high sodium, weight loss exceeding expected limits, and poor skin turgor. Treatment is gradual fluid liberalization.
  • Sodium Overload: Caused by excessive administration of sodium bicarbonate (during resuscitation) or hypertonic saline. Characterized by high sodium and weight gain.
  • Clinical Signs: Irritability, high-pitched cry, seizures, and intracranial hemorrhage (due to osmotic brain shrinkage pulling away from meninges).
  • Exam Trap: Never correct hypernatremia too rapidly. Reducing serum sodium faster than 0.5 to 1.0 mEq/L per hour (or 10 to 12 mEq/L per 24 hours) can cause a rapid shift of water into brain cells, leading to cerebral edema, seizures, and death.

Potassium (K+)

• Normal Range: 3.5 to 5.5 mEq/L (may accept up to 6.0 mEq/L in ELBW infants during the first 72 hours).
• Hypokalemia (<3.5 mEq/L):
  • Causes: Diuretic therapy (furosemide), gastrointestinal losses (suctioning, vomiting), or inadequate intake.
  • EKG Changes: Flattened T waves, prominent U waves, ST-segment depression, and prolonged QT interval.
  • Treatment: Add potassium to maintenance IV fluids (usual maintenance is 1 to 2 mEq/kg/day). Never administer potassium as a rapid IV push; it must be infused slowly (maximum rate 0.5 mEq/kg/hour).
• Hyperkalemia (>6.0 mEq/L):
  • Causes: Renal failure, metabolic acidosis (causes intracellular K+ to exchange with extracellular H+), tissue trauma (hemolysis, IV infiltration), and non-oliguric hyperkalemia of prematurity (occurs in ELBW infants on DOL 1-2 due to shift of potassium out of immature cells despite adequate urine output).
  • EKG Changes: Peaked T waves (earliest sign), followed by prolonged PR interval, flattened P waves, widened QRS, and ultimately a sinusoidal wave pattern progressing to ventricular fibrillation or asystole.
  • Clinical Management:
    1. Calcium Gluconate 10%: Administer 1 mL/kg (100 mg/kg) IV over 5-10 minutes. Action: Stabilizes the cardiac cell membrane (does not lower serum potassium). Monitor heart rate; hold if bradycardia occurs.
    2. Sodium Bicarbonate: 1 to 2 mEq/kg IV. Action: Corrects acidosis and shifts potassium into cells.
    3. Insulin and Dextrose Infusion: Regular insulin 0.1 units/kg with D10W. Action: Facilitates potassium entry into cells.
    4. Albuterol Nebulizer: Stimulates beta-2 receptors to shift potassium intracellularly.
    5. Furosemide (Lasix): 1 mg/kg IV to promote renal excretion (only if renal function is intact).
    6. Peritoneal Dialysis: Rescued for refractory cases.

Calcium (Ca2+)

• Normal Ranges: Total Calcium: 8.5 to 10.2 mg/dL; Ionized Calcium (physiologically active): 4.4 to 5.3 mg/dL (1.1 to 1.3 mmol/L).
• Hypocalcemia: Total <7.5 mg/dL (preterm <7.0 mg/dL) or ionized <4.4 mg/dL.
  • Early-Onset (<72 hours): Seen in preterm infants (loss of maternal calcium transfer), infants of diabetic mothers (IDM) (due to maternal hypomagnesemia suppressing infant parathyroid hormone), and infants with perinatal asphyxia or sepsis.
  • Late-Onset (>72 hours): Caused by high-phosphorus formulas, hypomagnesemia, or DiGeorge syndrome (absent parathyroid glands).
  • Clinical Signs: Jitteriness, muscle tremors, high-pitched cry, apnea, and seizures.
  • EKG Changes: Prolonged QT interval.
  • Treatment: Calcium gluconate 10% (100 to 200 mg/kg IV slowly over 10-30 minutes).
  • Exam Trap: Calcium gluconate is highly irritating to tissues. Assess IV patency before and during administration. Extravasation causes severe tissue necrosis and calcification (calcinosis cutis). Always monitor heart rate during infusion; rapid administration can cause severe bradycardia and sinus arrest.
• Hypercalcemia: Total >11 mg/dL or ionized >5.3 mg/dL.
  • Causes: Maternal hypocalcemia, hyperparathyroidism, or subcutaneous fat necrosis (calcium released from necrotic fat cells).
  • Clinical Signs: Hypotonia, lethargy, poor feeding, constipation, and polyuria.
  • EKG Changes: Shortened QT interval.
  • Treatment: Hydration with normal saline and furosemide to promote calcium excretion.

Magnesium (Mg2+)

• Normal Range: 1.6 to 2.8 mg/dL
• Hypomagnesemia (<1.5 mg/dL):
  • Causes: Maternal diabetes, placental insufficiency, or chronic diuretic use.
  • Clinical Connection: Hypomagnesemia impairs parathyroid hormone (PTH) secretion and action. If a neonate has hypocalcemia that does not respond to calcium administration, check magnesium levels. Refractory hypocalcemia cannot be corrected until hypomagnesemia is resolved.
  • Treatment: Magnesium sulfate 50% (25 to 50 mg/kg or 0.05 to 0.1 mL/kg IV or IM).
• Hypermagnesemia (>2.8 mg/dL):
  • Causes: Almost exclusively caused by maternal administration of magnesium sulfate for preeclampsia or fetal neuroprotection.
  • Clinical Signs: Neuromuscular depression, hypotonia, weak suck, respiratory depression, apnea, and delayed meconium passage (due to gut hypomotility).
  • Treatment: Supportive care (ventilatory support if needed), hydration, and calcium gluconate to temporarily reverse neuromuscular blockade if life-threatening.

---

Clinical Indicators & Monitoring

To safely manage fluids, the neonatal nurse must synthesize several clinical indicators:

• Urine Output: Normal is 1 to 3 mL/kg/hour. Oliguria is defined as <1 mL/kg/hour (critical in the first 24 hours of life, though some delay in first void up to 24 hours is normal). Anuria is no urine output.
• Urine Specific Gravity: Normal range is 1.002 to 1.012. A value >1.015 indicates concentrated urine (dehydration), while <1.002 indicates dilute urine (fluid overload or inability of preterm kidneys to concentrate urine).
• Serum Osmolality: Normal is 275 to 290 mOsm/kg. Elevated values (>295 mOsm/kg) indicate dehydration.
• Physical Exam: Check for fontanelle status (sunken in dehydration, bulging in fluid overload), skin turgor, perfusion, and presence of edema.